The American Diabetes Association has issued a guidance statement that cautions against using compounded versions of popular GLP-1 diabetes and weight-loss drugs such as Wegovy and Zepbound.

Human resources and benefits leaders find themselves in a challenging position. Their companies' health care costs have ...

While many of the barriers to improving access to mental health care are deeply rooted in our health care systems, they are ...

One will make it easier for administrators to use birthdates on forms when Social Security numbers are missing.

A recent case clarifies a significant legal principle that owners of businesses that are obligated to contribute to ...

Judges have been wrestling with state efforts to regulate PBMs, what health plans have to cover, and disputes over medical ...

With burnout and mental health challenges rising, now is the time to adopt family-focused benefits that would make a ...

Expect a growing wave of innovation and adoption of in-plan retirement income solutions for 401(k) plans, reflecting the ...

The second new law, the Paperwork Burden Reduction Act, was introduced by Rep. Jason Smith, R-Mo. The IRS has already been ...

Better pay and benefits have stabilized employee turnover at U.S. hospitals, the latest Benefits Survey of Hospitals from Aon found. The decreases in turnover since 2023 are significant.

There is so much opportunity in 2025 and beyond to make retirement savings work better for everyone, according to the Aspen ...

California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.